BOSTON--Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today reported financial results for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback